Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Addolorato

Showing results (81-90 of 197) with videos related to

Pageof 20
Sort By:
Alcohol (Fayetteville, N.Y.)|November 14, 2018
Repetitive transcranial magnetic stimulation: Re-wiring the alcoholic human brainMarco Diana, Corinna Bolloni, Mariangela Antonelli, et al.
European Journal of Internal Medicine|June 14, 2024
Low-dose ondansetron: A candidate prospective precision medicine to treat alcohol use disorder endophenotypesBankole Johnson, Hannu Alho, Giovanni Addolorato, et al.
Scandinavian Journal of Gastroenterology|July 21, 2005
Reduced plasma ghrelin concentration in celiac disease after gluten-free diet treatmentEsmeralda Capristo, Sara Farnetti, Geltrude Mingrone, et al.
Internal and Emergency Medicine|June 22, 2014
An 85-year-old man with acute-onset of confusion and dyspnea after a fall: a diagnostic challengeAntonio Mirijello, Vincenzo Zaccone, Michele Impagnatiello, et al.
Expert Opinion on Drug Safety|December 27, 2019
Post-marketing and clinical safety experience with sodium oxybate for the treatment of alcohol withdrawal syndrome and maintenance of abstinence in alcohol-dependent subjectsGiovanni Addolorato, Otto-Michael Lesch, Icro Maremmani, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 19, 2011
Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trialGiovanni Addolorato, Lorenzo Leggio, Anna Ferrulli, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|June 15, 2007
Coenzyme Q 10 and cardiovascular risk factors in idiopathic sudden sensorineural hearing loss patientsGabriella Cadoni, Simona Scipione, Stefania Agostino, et al.
Current Pharmaceutical Design|May 21, 2010
Turning the clock ahead: potential preclinical and clinical neuropharmacological targets for alcohol dependenceLorenzo Leggio, Silvia Cardone, Anna Ferrulli, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 16, 2009
Is cortisol involved in the alcohol-related fat mass impairment? A longitudinal clinical studyLorenzo Leggio, Noemi Malandrino, Anna Ferrulli, et al.
European Journal of Internal Medicine|March 23, 2024
Safety and compliance of long-term low-dose ondansetron in alcohol use disorder treatmentGiovanni Addolorato, Hannu Alho, Paula Bresciani M De Andrade, et al.
Pageof 20

Showing results (81-90 of 197) with videos related to

Sort By:
Pageof 20
Alcohol (Fayetteville, N.Y.)|November 14, 2018
Repetitive transcranial magnetic stimulation: Re-wiring the alcoholic human brainMarco Diana, Corinna Bolloni, Mariangela Antonelli, et al.
European Journal of Internal Medicine|June 14, 2024
Low-dose ondansetron: A candidate prospective precision medicine to treat alcohol use disorder endophenotypesBankole Johnson, Hannu Alho, Giovanni Addolorato, et al.
Scandinavian Journal of Gastroenterology|July 21, 2005
Reduced plasma ghrelin concentration in celiac disease after gluten-free diet treatmentEsmeralda Capristo, Sara Farnetti, Geltrude Mingrone, et al.
Internal and Emergency Medicine|June 22, 2014
An 85-year-old man with acute-onset of confusion and dyspnea after a fall: a diagnostic challengeAntonio Mirijello, Vincenzo Zaccone, Michele Impagnatiello, et al.
Expert Opinion on Drug Safety|December 27, 2019
Post-marketing and clinical safety experience with sodium oxybate for the treatment of alcohol withdrawal syndrome and maintenance of abstinence in alcohol-dependent subjectsGiovanni Addolorato, Otto-Michael Lesch, Icro Maremmani, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 19, 2011
Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trialGiovanni Addolorato, Lorenzo Leggio, Anna Ferrulli, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|June 15, 2007
Coenzyme Q 10 and cardiovascular risk factors in idiopathic sudden sensorineural hearing loss patientsGabriella Cadoni, Simona Scipione, Stefania Agostino, et al.
Current Pharmaceutical Design|May 21, 2010
Turning the clock ahead: potential preclinical and clinical neuropharmacological targets for alcohol dependenceLorenzo Leggio, Silvia Cardone, Anna Ferrulli, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 16, 2009
Is cortisol involved in the alcohol-related fat mass impairment? A longitudinal clinical studyLorenzo Leggio, Noemi Malandrino, Anna Ferrulli, et al.
European Journal of Internal Medicine|March 23, 2024
Safety and compliance of long-term low-dose ondansetron in alcohol use disorder treatmentGiovanni Addolorato, Hannu Alho, Paula Bresciani M De Andrade, et al.
Pageof 20